Institutet för Hälso- och
Sjukvårdsekonomi
Box 2127
SE-220 02 Lund
Besök: Råbygatan 2
Tel: 046-32 91 00
ihe[at]ihe.se

Nilsson Andreas
fil mag | bitr projektledare

Arbetsområden

Andreas har en filosofie masterexamen från Lunds Universitet med huvudämne nationalekonomi.
Han arbetar framförallt med projekt relaterade till diabetes och diabetes modellering.

URVAL PRESENTATIONER

Traditional Risk Factors in T2DM Modeling: An Example Using Statins and the UKPDS 82 Outcomes Model”, Presented at Economics, simulation modelling & diabetes: The Mt Hood 2016 Challenge, St. Gallen, Switzerland, September 17-18, 2016. Johansen P, Willis M, Nilsson A, Asseburg C and Neslusan C

“The Role of Estimated Glomerular Filtration Rate (eGFR) in Cost-Effectiveness (CE) Analyses Using Canagliflozin (CANA) vs Sulfonylurea (SU) to Treat Type 2 Diabetes Mellitus (T2DM)”, Presented at ADA 76th Scientific Sessions, New Orleans, LA, USA, June 10-14, 2016, Neslusan C, Willis M, Johansen P, Schroeder M, Nilsson A, Chan E, Asseburg C, Schubert A

“Time Until Insulin Initiation for Canagliflozin (CANA) Versus Sitagliptin (SITA) in Dual Therapy and Triple Therapy for Type 2 Diabetes Mellitus (T2DM) in the UK”, Presented at ADA 76th Scientific Sessions, New Orleans, LA, USA, June 10-14, 2016, Schroeder M, Chan E, Willis M, Johansen P, Nilsson A, Schubert A, Neslusan C

“Time Until Insulin Initiation for Canagliflozin (CANA) Versus Dapagliflozin (DAPA) and Empagliflozin (EMPA) in Dual and Triple Therapy for Type 2 Diabetes Mellitus (T2DM) in the UK”, Presented at ISPOR 21st Annual International Meeting, Washington, WA, USA, May 21-25, 2016, Schroeder M, Chan E, Willis M, Johansen P, Nilsson A, Schubert A, Neslusan C

“Update of the Model Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)”, Presented at ISPOR 21st Annual International Meeting, Washington, WA, USA, May 21-25, 2016, Asseburg C, Willis M, Johansen P, Nilsson A, Neslusan C, Schroeder M

“The Economic Consequences of Clinical Inertia in Treatment Intensification for Type 2 Diabetes Mellitus (T2DM) in the UK”, Podium Presentation at EASD 51st Annual Meeting, Stockholm, Sweden, September 14-18, 2015, Willis M, Neslusan C, Johansen P, Nilsson A, Asseburg C

“Impact of the Framingham Offspring Study (FOS) vs. Kaiser Permanente Northwest (KPNW) Prediction Equations for Diabetes Mellitus in Economic Modelling of T2DM”, Presented at EASD 51st Annual Meeting, Stockholm, Sweden, September 14-18, 2015, Asseburg C, Johansen P, Nilsson A, Willis M


Urval av publiceringar

Willis M, Asseburg C, Nilsson A, Johnsson K & Kartman B
Multivariate Prediction Equations for HbA1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modelling
Value in Health, 2017 Mar; 20 (3): 357-371
Published online: December 2016


Willis M, Johansen P, Nilsson A and Asseburg C
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
PharmacoEconomics 2017; 35(3): 375-96
Publicerad online: 12 november 2016 


© IHE 2017